Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
about
Regular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with salmeterol for chronic asthma: serious adverse eventsBeta-adrenoceptor profile of ractopamine HCl in isolated smooth and cardiac muscle tissues of rat and guinea-pigThe role of beta1- and beta2-adrenoceptors in the inhibition of gastric acid secretion in the dogAcute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunctionModulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzymeA high performance liquid chromatographic method for the determination of albuterol enantiomers in human serum using solid phase extraction and chemical derivatization.Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation.Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses.Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness.Determination of the relative bioavailability of salbutamol to the lung following inhalation.Comparison of the beta2-adrenoceptor selectivity of rimiterol, salbutamol and isoprenaline by the intravenous route in man.Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.Evaluation of the effects of isoprenaline and salbutamol aerosols on airways obstruction and pulse rates of children with asthmaBronchodilator and cardiac effects of isoprenaline, orciprenaline, and salbutamol aerosols in asthmaDosage of oral salbutamol in asthmatic children.Actions of the sympathomimetic bronchodilator, rimiterol (R798), on the cardiovascular, respiratory and skeletal muscle systems of the anaesthetized cat.Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog.Effect of acetylcholine on changes in contractility, heart rate and phosphorylase activity produced by isoprenaline, salbutamol and amino-phylline in the perfused guinea-pig heart.Investigation of occurrence of tolerance to bronchodilator drugs in chronically pretreated guinea-pigsSelectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat.Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog.Differentiation of metabolic adrenoceptors.Profile of beta-adrenoceptors in femoral, superior mesenteric and renal vascular beds of dogs.Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle.Cardiorespiratory effects of intravenous isoprenaline and salbutamol in dogs.An analysis of the coronary vascular responses to catecholamines, using a modified Langendorff heart preparation.Drugs for asthmaPotency and selectivity in vitro of compounds related to isoprenaline and orciprenaline on beta-adrenoceptors in the guinea-pigSalbutamol--an effective bronchodilator.Salbutamol in treatment of heart failure.Haemodynamic effects of oral salbutamol alone and in combination with sublingual isosorbide dinitrate in patients with severe congestive cardiac failure.Salbutamol in cardiogenic shock complicating acute myocardial infarction.Simultaneous determination of salbutamol and terbutaline at overdose levels in human plasma by high performance liquid chromatography with electrochemical detection.A double-blind trial of salmefanol, a new bronchodilatorModulation of in vitro erythropoiesis. The influence of beta-adrenergic agonists on erythroid colony formation.beta(2)-Adrenergic agonist administration and strength training.Asthma: a simple concept but in reality a complex disease.β2 Agonists
P2860
Q24200353-DFDC78F1-31FA-490F-AA75-EEC222B99E7DQ24241250-40D0506D-A932-4E7A-87E7-07E8070C7C21Q24241960-866C3627-3DEF-4C37-B85F-0D2786D7653BQ28254796-7305B1C0-EFE5-4B1D-896D-5277DCC54A36Q28322073-739D8F99-C953-4911-9141-E14ACBE9CACCQ28335541-E98B68B5-9106-475F-AE33-0787BA195B6AQ28357383-72636435-8890-4A37-9C98-B06E80187B04Q30963407-554B6159-FD5A-43AE-B2F3-B4531295EB1DQ34092070-BE112515-F8C4-4329-8298-1CE32D281E5EQ34382903-2AF5E16C-7311-4531-B45F-C0178618B483Q34402775-E224D0D3-4CCD-4779-B7C0-5E57B54F380DQ34403244-89379F9C-FD57-4D0E-96BE-4D3A53A67662Q34451469-BEA48430-5453-47FB-9396-60FB410EA34FQ34518804-65A138C1-895E-4DD2-8653-173CBB624599Q35148247-7BBD49C1-D1FC-471C-A68B-4EA7A02772C0Q35149013-2CDD4DC0-A712-4A3A-881A-437F1006E729Q35149394-FA5000F9-AE00-4517-B379-BC9C668DC9BFQ35174332-416F0389-7971-40E4-AAAC-83120C869419Q35174782-73D7A0D2-6DD1-4F59-9AA3-F72AF132114EQ35174853-CEB322BB-536E-40FD-A392-21652906BFC1Q35175718-C9B0D6EF-C03C-4679-A5C9-349E30CB683FQ35176106-6792E71C-6802-4422-A1CB-76878B9262B4Q35176847-CE775619-B6E1-458A-AC08-CECE8C7DC968Q35176860-09D92B05-251B-4D28-9FE1-0058EA6021B8Q35176992-2DBFBD80-FE4F-4922-87BC-9694C9504C51Q35225831-BC2BF0D6-A3B1-4504-8E55-6E76E37125A2Q35226219-3CDA260E-3997-4D87-B6DB-7A7A28C9EBCCQ35226310-BB093D55-3E4C-4A0A-9AE2-9B211052C444Q35566594-969657A4-6822-4F9B-A6C3-B6E1231CAB2CQ35601525-C7F9AAA6-7A5D-4F23-A8CD-37C3EDCD7DF8Q35925912-14D95C37-C655-4ECC-82F7-0B9D73E7A553Q36770781-E6DB389B-BEA5-4426-8DBC-F7D5A04543EBQ36770847-078E5857-CC12-4B0F-B9EC-C0833442EBDBQ36772896-34333DF2-D455-4B39-9737-AFAD040B0A8AQ36776558-FB6AE874-EA9E-43B5-A9C1-623778675439Q36811156-C5B18A26-F157-4737-A4B7-F1A754E64C6FQ37045401-F90B792C-835E-4BCA-AF62-E9DFD5007A53Q37667545-7458E169-77C0-431D-8F97-FF9B3EFC98D5Q37880256-61B1B440-C1DB-4E42-9949-ECCC2815151BQ38791742-4331845A-C60E-4F98-952C-1A40B148A4F3
P2860
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
description
1969 nî lūn-bûn
@nan
1969年の論文
@ja
1969年学术文章
@wuu
1969年学术文章
@zh-cn
1969年学术文章
@zh-hans
1969年学术文章
@zh-my
1969年学术文章
@zh-sg
1969年學術文章
@yue
1969年學術文章
@zh
1969年學術文章
@zh-hant
name
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
@en
type
label
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
@en
prefLabel
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
@en
P2093
P2860
P1476
Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1969.TB07975.X
P407
P577
1969-01-01T00:00:00Z